Flickinger K, Wilson K, Rossiter N, Hunger A, Vishwasrao P, Lee T
Sci Adv. 2024; 10(40):eadq3591.
PMID: 39365851
PMC: 11451515.
DOI: 10.1126/sciadv.adq3591.
Matherly L, Schneider M, Gangjee A, Hou Z
Expert Opin Drug Metab Toxicol. 2022; 18(10):695-706.
PMID: 36239195
PMC: 9637735.
DOI: 10.1080/17425255.2022.2136071.
Apaolaza I, Jose-Eneriz E, Valcarcel L, Agirre X, Prosper F, Planes F
PLoS Comput Biol. 2022; 18(3):e1009395.
PMID: 35286311
PMC: 8947600.
DOI: 10.1371/journal.pcbi.1009395.
Yan H, Su R, Xue H, Gao C, Li X, Wang C
Front Immunol. 2022; 12:789334.
PMID: 34975886
PMC: 8719371.
DOI: 10.3389/fimmu.2021.789334.
Artacho A, Isaac S, Nayak R, Flor-Duro A, Alexander M, Koo I
Arthritis Rheumatol. 2020; 73(6):931-942.
PMID: 33314800
PMC: 11293279.
DOI: 10.1002/art.41622.
The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
Matherly L, Hou Z, Gangjee A
Cancer Chemother Pharmacol. 2017; 81(1):1-15.
PMID: 29127457
PMC: 5756103.
DOI: 10.1007/s00280-017-3473-8.
The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.
Matherly L, Wilson M, Hou Z
Drug Metab Dispos. 2014; 42(4):632-49.
PMID: 24396145
PMC: 3965896.
DOI: 10.1124/dmd.113.055723.
The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.
Desmoulin S, Hou Z, Gangjee A, Matherly L
Cancer Biol Ther. 2012; 13(14):1355-73.
PMID: 22954694
PMC: 3542225.
DOI: 10.4161/cbt.22020.
Selective killing of preneoplastic and neoplastic cells by methotrexate with leucovorin.
Chow M, Rubin H
Proc Natl Acad Sci U S A. 1998; 95(8):4550-5.
PMID: 9539775
PMC: 22527.
DOI: 10.1073/pnas.95.8.4550.
Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells.
Cai J, Lee C
Biochem J. 1996; 320 ( Pt 3):991-5.
PMID: 9003390
PMC: 1218025.
DOI: 10.1042/bj3200991.
5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
Daluge S, Purifoy D, Savina P, St Clair M, Parry N, Dev I
Antimicrob Agents Chemother. 1994; 38(7):1590-603.
PMID: 7526782
PMC: 284598.
DOI: 10.1128/AAC.38.7.1590.
Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma.
Eells J, Spector R
Neurochem Res. 1983; 8(11):1451-7.
PMID: 6656991
DOI: 10.1007/BF00965000.
Determination of ribonucleosides, deoxyribonucleosides, and purine and pyrimidine bases in adult rabbit cerebrospinal fluid and plasma.
Eells J, Spector R
Neurochem Res. 1983; 8(10):1307-20.
PMID: 6656989
DOI: 10.1007/BF00964000.
Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
Cabral S, Leis S, Bover L, Nembrot M, Mordoh J
Proc Natl Acad Sci U S A. 1984; 81(10):3200-3.
PMID: 6587345
PMC: 345249.
DOI: 10.1073/pnas.81.10.3200.
Synchronization of human leukemic cells: relevance for high-resolution chromosome banding.
Gallo J, Ordonez J, Brown G, Testa J
Hum Genet. 1984; 66(2-3):220-4.
PMID: 6585345
DOI: 10.1007/BF00286605.
Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.
Ellims P
Cancer Chemother Pharmacol. 1982; 10(1):1-6.
PMID: 6186411
DOI: 10.1007/BF00257227.
Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexate.
Umbach G, Spitzer G, Ajani J, Hug V, Thames H, Rudolph F
J Cancer Res Clin Oncol. 1986; 111(3):273-6.
PMID: 3733857
DOI: 10.1007/BF00389244.
Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
Hirose M, Takeda E, Ninomiya T, Kuroda Y, Miyao M
Br J Cancer. 1987; 56(4):413-7.
PMID: 3479994
PMC: 2001816.
DOI: 10.1038/bjc.1987.216.
Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay.
Hughes J, deFazio A, Tattersall M
Br J Cancer. 1988; 57(5):459-63.
PMID: 3395552
PMC: 2246399.
DOI: 10.1038/bjc.1988.107.
Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
Hughes J, Tattersall M
Br J Cancer. 1989; 59(3):381-4.
PMID: 2930702
PMC: 2247054.
DOI: 10.1038/bjc.1989.76.
